| Cover and Content | |
| 1-6 |
| The role of carboxylesterase enzymes in capecitabine therapy | |
| Stanila Stoeva, Nikolay Conev, Petko Marinov | 7-17 |
| Aerosol vaccines – perspectives and therapeutic impact | |
| Stanimira Zasheva, Viliana Gugleva, Velichka Andonova | 18-25 |
| NАТ technology – a step forward in hepatitis C screening in Bulgaria | |
| Diana Ivanova, Zhanina Yordanova, Milena Karagyozova, Galina Yaneva, Delyan Ivanov | 26-31 |
| QSAR modeling for prediction of binding to DNA or proteins of dermal metabolites of newly synthesized hydrazones | |
| Nadya Agova, Svetlana Georgieva, Sylvia Stamova, Yana Koleva | 32-36 |
| FT-IR spectral analysis for a newly obtained structure analog of bexarotene | |
| Nadya Agova, Svetlana Georgieva, Sylvia Stamova, Boryana Mihaylova | 37-40 |